Thomas A. Satterfield, Jr. Reports New 5.1% Passive Stake in Lantern Pharma Inc. (LTRN)

On April 3, 2026, Thomas A. Satterfield, Jr. filed a Schedule 13G with the SEC, reporting a new 5.1% passive stake in Lantern Pharma Inc. (LTRN). As of the event date on March 30, 2026, Satterfield beneficially owns 570,000 shares of common stock. The filing details a complex ownership structure involving several entities controlled by Satterfield: 45,000 shares held by Tomsat Investment & Trading Co., Inc.; 250,000 shares held by Caldwell Mill Opportunity Fund, LLC; 150,000 shares held by A.G. Family L.P.; and 30,000 shares held by Satterfield Vintage Investments, L.P. Additionally, Satterfield holds 95,000 shares with sole voting and dispositive power. The calculation of the 5.1% ownership is based on 11,254,697 shares outstanding as of March 13, 2026. The filing is made under Rule 13d-1(c), indicating that the shares were acquired for investment purposes and not with the intent to influence or change the control of the issuer.